Upstream of everything else
The hormonal cascade that governs reproduction runs from the hypothalamus down. Kisspeptin acts at the top of it, on neurons that release GnRH, which in turn drives the pituitary hormones further down the chain.
That makes it a useful research tool. Intervening upstream lets you study how the whole system is regulated rather than what happens when you push on one output, which is what most other approaches do.
Anyone asking what is kisspeptin is usually pointed straight at reproduction, but the more useful framing is a signal that sits above the reproductive axis rather than inside it, shaping the hormones downstream instead of being one of them. That position is the reason it draws research interest.
An odd name, an odd history
The gene was identified in cancer research as a metastasis suppressor, and named after a local confection. Its role in reproductive signalling was discovered later, when mutations in its receptor were linked to a failure of puberty.
That sequence of events explains why the literature is split across two fields that do not always cite each other. If you are reading about kisspeptin, it is worth checking which of the two a given paper belongs to.
That split has a practical edge for anyone searching. The oncology side is often written about the gene under its KISS1 designation, while the reproductive work is written about the peptide and its receptor, so half the record can be missed by a search that uses only one of those names.
| Gene | KISS1 |
| Receptor | KISS1R, also called GPR54 |
| Position | Upstream of GnRH release |
| First described | In cancer research, later in reproduction |
| Format | Pre-filled peptide pen |
| Purity | ≥ 99% (HPLC) |
| Evidence base | Animal models, receptor genetics, limited human work |
| Category | Research use only |
Laboratory information throughout. None of it amounts to a clinical finding.
What is being studied
Current work examines how kisspeptin neurons integrate signals about energy availability and other inputs before passing them down the chain. That places it at an interesting junction between metabolic and reproductive research.
Human work exists but is limited in scale, and most of what is known about the mechanism comes from animal models and from the genetics of receptor mutations.
Both halves are worth reading in the original: the results on PubMed for the mechanistic work, and the registry entries on ClinicalTrials.gov for the studies that have been run in people, which are easier to count than to summarise. As supplied it is a pre-filled peptide pen, the format most of the catalogue uses.
What a certificate settles for kisspeptin
Kisspeptin is a defined sequence, which means the identity question has a clean answer: one compound, one purity figure, a single line on the certificate. That is a different situation from an extract, and it is the case the quality and COA standard is built to record.
Where it gets interesting is the company it keeps. In this catalogue it sits beside compounds acting much further down the same chain, and oxytocin is the clearest contrast: a peptide with its own receptor and its own behavioural literature, studied for what happens at the far end rather than for how the cascade is set going.
Kisspeptin in the catalogue
Each lot passes a 99% HPLC threshold and carries its own analysis sheet.
Where Kisspeptin fits in
Further reading that fills in what this page only touches on.
About Kisspeptin
Answers to what our inbox asks most.